6h
Bizcommunity on MSNSanofi-Novavax deal in jeopardy as FDA halts vaccine approvalDr Sara Brenner, the FDA's principal deputy commissioner, has paused the approval process for Novavax's Covid-19 vaccine by ...
The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...
Continuing to ask questions on an issue that has been answered multiple times, by multiple people, introduces doubt and anxiety. Our children deserve better.
Significant layoffs across the FDA, CDC and NIH are ushering in a new era of public health under the Trump administration.
Medical researchers helped tame a worldwide pandemic, but they may be powerless against the financial disease rapidly ...
Against the backdrop of a rapidly expanding measles outbreak, what we need right now is urgent assistance from the federal government to support immunization and strengthen vaccine delivery, not more ...
Over the last two months, the pharmaceutical industry has remained on the sidelines as Health and Human Services Secretary Robert F. Kennedy Jr. and Elon Musk’s Department of Government Efficiency ...
Dr. Marks was asked to leave and then subsequently wrote that he did not want to become “subservient to [Secretary Kennedy’s] misinformation and lies.” Peter Marks is not a hero of the resistance but ...
It comes on the heels of the FDA's top vaccine scientist Peter Marks' exit from the agency, which will be effective April 5.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results